VAMP-4 activators describe a specific category of compounds that target and increase the activity of Vesicle-associated membrane protein 4 (VAMP-4), which is involved in vesicular transport processes within cells. VAMP-4 is a member of the SNARE (Soluble NSF Attachment Protein Receptors) protein family, which plays a fundamental role in the docking and fusion of vesicles with target membranes-a critical step in intracellular trafficking, including the transport of proteins and lipids between different organelles and the plasma membrane.
Activators of VAMP-4 may function through direct binding interactions, which can enhance the protein's ability to engage with other SNARE proteins, such as syntaxins or SNAP (Synaptosomal-associated protein) proteins, to form the SNARE complex. The formation of this complex is essential for bringing vesicles close to membranes to facilitate fusion. Direct activators may thus promote SNARE complex assembly either by stabilizing VAMP-4 in an active conformation or by increasing its local concentration at sites of vesicle fusion. Indirect activators, alternatively, might affect VAMP-4 activity by modulating cellular signaling pathways that influence the protein's trafficking, membrane localization, or its interaction with other SNARE components. These pathways could alter the phosphorylation state of VAMP-4, affect the lipid environment of the membranes where VAMP-4 operates, or regulate the expression levels of VAMP-4 or other SNARE proteins.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing levels of cyclic adenosine monophosphate (cAMP), which can promote VAMP-4 translocation to the plasma membrane. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, leading to increased cAMP levels, which can promote VAMP-4 translocation to the plasma membrane. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine activates beta-adrenergic receptors, increasing cAMP levels, which can promote VAMP-4 translocation to the plasma membrane. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, which can promote VAMP-4's translocation to the plasma membrane. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates VAMP-4, promoting its activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable analogue of cAMP that can promote VAMP-4 translocation to the plasma membrane. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a membrane-permeable cAMP analogue that can promote VAMP-4 translocation to the plasma membrane. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterases, leading to increased cAMP levels, which can promote VAMP-4 translocation to the plasma membrane. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, leading to increased cAMP levels, which can promote VAMP-4 translocation to the plasma membrane. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide inhibits phosphodiesterases, leading to increased cAMP levels, which can promote VAMP-4 translocation to the plasma membrane. | ||||||